Chemical Cos. Settle Spat Over Cystic Fibrosis Drug

Law360, New York (July 11, 2006, 12:00 AM EDT) -- Chemical company Solvay Pharmaceuticals Inc. has resolved a lawsuit against Global Pharmaceuticals and Impax Laboratories Inc., claiming that the companies falsely advertised their products as generic versions of a brand-name drug used to treat patients with cystic fibrosis.

As part of the settlement announced Tuesday, Global and Impax will pay $23 million to Solvay and will stop their marketing practices dating back to 1998 that imply that its products are generic equivalents to Creon, the brand-name product.

Impax and Global, which markets the generic products made...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.